Lilly to Showcase Data from its Alzheimer's Disease Portfolio at the Alzheimer's Association International Conference 2014 (AAIC 2014)
Highlights include additional analyses from Phase 3 and ongoing open-label studies, discovery research on the potential use of combination therapy and data on the impact of beta-amyloid imaging on
Baxter Names Chief Financial Officers for New Biopharmaceutical Spin-Off and Baxter International Inc.
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION
NASCAR Driver Ryan Reed Finishes Fourth at the Subway Firecracker 250 at Daytona International Speedway
On and off the track, Reed shows that diabetes doesn't slow him down
INDIANAPOLIS and ALEXANDRIA, Va.
Technical Pulse on Pharma Stocks -- Research on Pfizer, Hospira, Endo Intl., and Nektar Therapeutics
Editor Note: For more information about this release, please scroll to bottom.
LONDON, July 7, 2014
GSK receives EU marketing authorisation for Mekinist™ (trametinib) for patients with unresectable or metastatic melanoma with a BRAF V600 mutation
Teva Files Citizen Petition with the U.S. Food and Drug Administration (FDA) Regarding the Complexity of COPAXONE® (glatiramer acetate) Following the Agency's Guidance
--$100,000 World of Difference grant will fund research lacking today
BLOOMFIELD, Conn., July 1, 2014
Amgen Receives FDA Breakthrough Therapy Designation For Investigational BiTE® Antibody Blinatumomab In Acute Lymphoblastic Leukemia
Breakthrough Designation Reinforces Significant Unmet Need in the Treatment of This Highly Aggressive Cancer
THOUSAND OAKS, Calif.
India Coronary Stent Market Would Continue to Grow in Double Digits and Abbott Vascular (NYSE:ABT) to Lead the Market
LONDON and NEW YORK, July 1, 2014 /PRNewswire/ --